amlodipine and atenolol

amlodipine has been researched along with atenolol in 152 studies

Research

Studies (152)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.32)18.7374
1990's25 (16.45)18.2507
2000's76 (50.00)29.6817
2010's36 (23.68)24.3611
2020's13 (8.55)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Bruno-Blanch, L; Gálvez, J; García-Domenech, R1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brobyn, R; Brown, RD; Frishman, WH; Johnson, BF; Reeves, RL; Wombolt, DG3
Cocco, G; de Bruijn, B; Tyler, HM1
Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A1
Bretnall, AE; Clarke, GS1
Biscione, F; Lanza, GA; Manzoli, A; Natale, A; Santarelli, P1
Davies, RF; Dessain, P; Foris, K; Habibi, H; Herbert, M; Klinke, WP; Lepage, S; Nadeau, C; Phaneuf, DC; Raman, S1
Ames, RP; Applegate, WB; Burris, JF; Davidov, ME; Mroczek, WJ; Ram, CV1
Channer, KS; Morice, AH; Stewart, AG; Woodmansey, PA1
Buttars, JA; Davies, RF; Dessain, P; Habibi, H; Klinke, WP; Lepage, S; Linden, W; Nadeau, C; Phaneuf, DC1
Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA1
Mulcahy, D1
Dees, A; Derkx, FH; Krijnen, P; Man in't Veld, AJ; Pieterman, H; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ1
Agodoa, LY; Glassock, R; Kirk, KA; Kusek, JW; Lee, JY; Randall, OS; Toto, RD; Wright, JT1
Cornell, CE; Faulkner, M; Greene, PG; Kopple, JD; Kusek, JW; Lee, JY; Milligan, S; Smith, DE1
Chronos, NA; Fox, K; Goodall, AH; Knight, CJ; Panesar, M; Patel, D; Wilson, DJ1
Baron, B; Bernaud, C; Hotton, JM; Kahn, JC; Marchand, X; Pathé, M; Rocha, P; Zannier, D1
Bernink, PJ; Bouwens, LH; Dunselman, PH; Herweijer, AH; Holwerda, KJ; van Kempen, LH1
Fox, KM; Knight, CJ1
Bartelink, A; Dees, A; Derkx, F; Krijnen, P; Man in't Veld, A; Schalekamp, M; van Jaarsveld, B1
Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P1
Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG1
Ford, MD; Kerns, WP; Kline, JA; Tomaszewski, CA; Yuan, TH1
Colonna, G; Lanza, GA; Maseri, A; Pasceri, V1
Donnan, PT; Lim, PO; MacDonald, TM1
Argekar, AP; Powar, SG1
Grote, L; Hedner, J; Kraiczi, H; Peker, Y1
Anderson, R; Hollenberg, NK; Williams, GH1
Chaswal, M; Shankar, N; Singh, S; Tandon, OP1
Frishman, W; Glasser, SP; Johnson, MF; Stone, P; White, WB1
Ekdahl, S; Karlson, BW; Pehrsson, SK; Persson, S; Ringqvist, I; Ulvenstam, G1
Fazzari, L; Mettimano, M; Migneco, A; Pichetti, F; Romano Spica, V; Savi, L; Specchia, L1
Deinum, J; Derkx, FH; Krijnen, P; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ1
Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H1
Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A1
Nieminen, MS; Oikarinen, L; Toivonen, L; Viitasalo, M1
Caulfield, MC; Collier, DJ; Eldridge, S; Feder, GS; Griffiths, CG; Hemingway, H; Kirby, PL; Poulter, NR1
Park, JB; Pu, Q; Schiffrin, EL1
Beevers, DG; Blann, AD; Gurney, D; Lip, GY; Spencer, CG1
Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST1
Lester, MH; Resnick, LM1
Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F1
Beevers, DG; Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG1
Guy, S; Herity, N; Silke, B; Tham, TC1
Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA1
Jiang, YY; Miao, CY; Shen, FM; Shu, H; Su, DF; Xu, LP1
Anderson, A; Bertram, D; Lauri, J; Morgan, T1
Jiang, YY; Miao, CY; Shen, FM; Su, DF; Xie, HH; Xu, LP1
Gratsianskiĭ, NA1
Kulschewski, A; Schrader, J1
Ling, G; Shen, FM; Su, DF; Xie, HH; Xu, LP1
Baykal, B; Baysan, O; Cincik, M; Kayir, H; Ozkan, M; Ozogul, C; Sag, C; Uzbay, IT; Uzun, M; Yokusoglu, M1
Karpov, IuA1
Füessl, HS1
Bilous, R1
Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D1
Collier, D; Cruickshank, K; Hughes, AD; Lacy, PS; O'Rourke, M; Stanton, A; Thom, SM; Thurston, H; Williams, B1
Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M1
Coleman, JJ; Kendall, MJ1
Coelho, EB; da Silva, CA; Fazan, R; Nobre, F; Salgado, HC1
Kähönen, M; Kööbi, T; Nieminen, T1
Dart, AM; Gatzka, CD; Kingwell, B1
Cameron, JD; Hope, SA; Meredith, IT1
Fournier, A; Safar, ME1
Feely, J; Mahmud, A1
Chiara Cavallini, M; Palmieri, V; Pini, R1
Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG1
Ahmed, M; Barman, RK; Hossain, MB; Ibne Wahed, MI; Islam, MA; Islam, R; Khan, A; Rahman, BM1
Rahn, KH1
Coyne, DW; Nath, V; Zheng, S1
Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT1
Buxton, M; Dahlöf, B; Jönsson, B; Kahan, T; Lindgren, P; Poulter, NR; Sever, PS; Wedel, H2
Cai, GJ; Ling, G; Liu, AJ; Liu, JG; Shen, FM; Su, DF1
Dahlof, B; Dobson, J; Gupta, AK; Poulter, NR; Sever, PS; Wedel, H1
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A1
Aubert, JF; Bouzourene, K; Hayoz, D; Mazzolai, L; Nussberger, J; Pellegrin, M1
Baykal, B; Baysan, O; Cincik, M; Kayir, H; Koz, C; Ozkan, M; Ozogul, C; Sag, C; Uzbay, IT; Uzun, M; Yokusoglu, M1
Mourad, JJ; Waeber, B1
Sundermeyer, M; Veeraputhiran, M1
Mehlsen, J1
Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H1
Han, SH; Kim, SJ; Koh, KK; Koh, Y; Lee, Y; Quon, MJ; Shin, EK1
Aryal, S; Skalko-Basnet, N1
Chen, YY; Han, P; Mehta, JL; Miao, CY; Sassard, J; Shen, FM; Su, DF; Xie, HH1
Chang, CL; Dahlof, B; Mastorantonakis, S; Poulter, NR; Sever, PS; Wedel, H1
Barrios, V; Escobar, C1
Atkins, N; Caulfield, M; Collier, D; Dicker, P; Dolan, E; McInnes, G; O'Brien, E; Stanton, AV; Thom, S1
Allemann, S; Chaturvedi, N; Hughes, A; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Stanton, A; Stettler, C; Tapp, R; Thom, S; Witt, N1
Bolbrinker, J; Huber, M; Kreutz, R; Scholze, J1
Davies, JE; Francis, DP; Hughes, AD; Manisty, CH; Mayet, J; McG Thom, SA; Parker, KH; Zambanini, A1
Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H1
Dutta, TK; Madanmohan, T; Pavithran, P; Prakash, ES1
Andrushchishina, TB; Morozova, TE1
Fiehn, A; Hegde, HV; Puri, GD1
Dahlöf, B; Dobson, JE; Dolan, E; Howard, SC; O'Brien, E; Poulter, NR; Rothwell, PM; Sever, PS1
Achouba, A; Boutouyrie, P; Laurent, S; Trunet, P1
Chaturvedi, N; Hughes, AD; Mayet, J; O'Brien, E; Poulter, NR; Sever, PS; Sharp, A; Stanton, AV; Tapp, RJ; Thom, SA1
Cappuccio, FP; Caulfield, M; Collier, D; Cruickshank, JK; Dobson, J; Eldridge, S; Feder, G; Gupta, AK; Poulter, NR; Sever, PS1
Del Giaccio, A; Eblen-Zajjur, A1
Buch, J; Caulfield, MJ; Collier, DJ; Dahlöf, B; Poulter, NR; Sever, PS; Wedel, H1
Hosseini, F; Mahmoudian, M; Nemati, F; Rahbar-Roshandel, N; Shafiei, M1
Peuhkurinen, K; Peuhkurinen, S; Risteli, J; Uusimaa, P; Vuolteenaho, O; Ylitalo, A1
Chang, CL; Dahlöf, B; Gupta, AK; Nasothimiou, EG; Poulter, NR; Sever, PS1
Berwanger, O; Mion Júnior, D; Ortega, KC; Silva, GV; Tsuji, RL1
Hotha, KK; Kallem, RR; Mullangi, R; Ravindranath, LK; Seshagirirao, JV; Spoorthy, YN1
Bespalova, LD; Kalyuzhin, VV; Kalyuzhina, EV; Kolesnikov, RN; Pushnikova, EY; Teplyakov, AT1
Baksi, AJ; Barron, AJ; Fitzgerald, D; Hughes, AD; Jabbour, RJ; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Sharp, A; Stanton, A; Surendran, P; Thom, S1
Jeffers, BW; Wang, JG; Yan, P1
Lamie, NT2
Amjad-Iranagh, S; Goharpey, F; Modarress, H; Yousefpour, A2
Cole, JB; Laes, JR; Williams, DM1
Kannappan, V; Mannemala, SS1
Atkins, E; Bennett, A; Burke, M; Chalmers, J; Chou, M; Chow, CK; Dehbi, HM; Hillis, G; Hilmer, S; Krum, H; Neal, B; Nelson, M; Patel, A; Peiris, D; Reid, CM; Rodgers, A; Rogers, K; Salam, A; Thakkar, J; Thom, S; Usherwood, T; Vo, K; Webster, R; Woodward, M1
Paradkar, SG; Sinha, SR1
Al-Abassi, FA; Al-Alsieni, AI; Anwar, F; Bacha, AO; Hejazi, MM; Kaleemuddin, M; Kazmi, I1
Collier, T; Godec, T; Gupta, A; Mackay, J; Pocock, S; Poulter, N; Sever, P; Whitehouse, A1
Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Simpson, LM1
Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM1
Del Pinto, R; Ferri, C; Parati, G1
Allo, MA; Bertera, FM; Carranza, A; Chiappetta, DA; Del Mauro, JS; Donato, M; Gelpi, RJ; González, GE; Gorzalczany, SB; Höcht, C; Morales, C; Morettón, MA; Polizio, AH; Prince, PD; Santander Plantamura, Y; Taira, CA1
Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V1
Godec, T; Gupta, AK; Mackay, J; Rostamian, S; Sever, PS; Whitehouse, A; Whiteley, WN1
Behera, G; Jayaraman, R; Murugesan, R; Nagaraj, GA; Subramanian, A; Thirunavukarasu, SC1
Du, Y; Kan, Z; Ma, M; Zhang, J; Zhang, X1
Du, Y; Feng, Z; Gan, J; Li, X; Ma, M; Miao, P; Zhang, J; Zhang, L1
Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C1
Bai, X; Huang, Z; Li, Q; Lin, X; Zhu, Y1
Bakker, ENTP; Coolen, BF; de Vos, J; Heijst, JA; Jongenelen, CAM; Naessens, DMP; Richard, E; Scholl, ER; Strijkers, GJ; Teunissen, CE; van der Wel, NN; VanBavel, E; Wilhelmus, MMM1
A Wartolowska, K; André, E; Biessels, GJ; Bousser, MG; Dichgans, M; Duering, M; Kerkhofs, D; Kopczak, A; Mansmann, U; Middeke, M; N Doubal, F; Norrving, B; Onkenhout, L; Rothwell, PM; S Stringer, M; Staals, J; Thrippleton, MJ; van den Brink, H; van Dinther, M; van Oostenbrugge, R; W Blair, G; Wardlaw, JM; Webb, AJ1
Abd El-Aziz, H; Zeid, AM1

Reviews

9 review(s) available for amlodipine and atenolol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
    Clinical cardiology, 2000, Volume: 23, Issue:7

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Chronotherapy; Delayed-Action Preparations; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Retrospective Studies; Verapamil

2000
[Old or new antihypertensives--which are better?].
    MMW Fortschritte der Medizin, 2005, Mar-31, Volume: 147, Issue:13

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors

2005
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
    Kardiologiia, 2005, Volume: 45, Issue:12

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil

2005
Will ASCOT change the form of anti-hypertensive therapy?
    Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:1

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Lipids; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors

2006
The Anglo-Scandinavian Cardiac Outcomes Trial-- blood pressure lowering arm.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:4

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic

2006
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
    Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic

2014
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
    Lancet (London, England), 2017, 03-11, Volume: 389, Issue:10073

    Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome

2017
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
    American journal of obstetrics and gynecology, 2020, Volume: 223, Issue:4

    Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index

2020

Trials

64 trial(s) available for amlodipine and atenolol

ArticleYear
A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
    American journal of hypertension, 1992, Volume: 5, Issue:10

    Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pulse

1992
A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
    Journal of cardiovascular pharmacology, 1988, Volume: 12 Suppl 7

    Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Patient Compliance; Random Allocation

1988
Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension.
    Journal of cardiovascular pharmacology, 1988, Volume: 12 Suppl 7

    Topics: Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation

1988
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid

1995
Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
    Cardiovascular drugs and therapy, 1994, Volume: 8, Issue:4

    Topics: Adult; Aged; Amlodipine; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Electrophysiology; Female; Heart; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia

1994
Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
    Journal of the American College of Cardiology, 1995, Mar-01, Volume: 25, Issue:3

    Topics: Amlodipine; Atenolol; Cross-Over Studies; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Time Factors

1995
Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
    Clinical cardiology, 1994, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Double-Blind Method; Drug Combinations; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pulse; Safety; Single-Blind Method; Triglycerides

1994
Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial.
    European journal of clinical pharmacology, 1993, Volume: 45, Issue:2

    Topics: Aged; Amlodipine; Angina Pectoris; Atenolol; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise Tolerance; Heart Rate; Humans; Male; Middle Aged; Time Factors

1993
Amlodipine versus atenolol in essential hypertension.
    The American journal of cardiology, 1994, Jan-27, Volume: 73, Issue:3

    Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Edema; Fatigue; Female; Headache; Heart Rate; Humans; Hypertension; Male; Middle Aged

1994
Relative importance of psychologic traits and severity of ischemia in causing angina during treadmill exercise. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
    Journal of the American College of Cardiology, 1993, Volume: 21, Issue:2

    Topics: Amlodipine; Angina Pectoris; Atenolol; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Psychological Tests; Regression Analysis

1993
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure

1996
Pointers from recent multicentre trials using ambulatory monitoring--placing placebo in perspective.
    European heart journal, 1995, Volume: 16, Issue:12

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Coronary Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Humans; Placebo Effect; Vasodilator Agents

1995
'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study.
    Contributions to nephrology, 1996, Volume: 119

    Topics: Adolescent; Adult; Aged; Amlodipine; Angiography; Antihypertensive Agents; Atenolol; Drug Resistance, Multiple; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Selection; Radionuclide Imaging; Renal Artery Obstruction

1996
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
    Controlled clinical trials, 1996, Volume: 17, Issue:4 Suppl

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black or African American; Blood Pressure; Drug Evaluation; Enalapril; Female; Humans; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Patient Selection; Pilot Projects; Quality Control; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Sample Size

1996
Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
    Controlled clinical trials, 1996, Volume: 17, Issue:4 Suppl

    Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Atenolol; Black or African American; Blood Pressure; Enalapril; Female; Humans; Hypertension, Renal; Male; Middle Aged; Multivariate Analysis; Pilot Projects; Prospective Studies; Quality of Life; Research Design

1996
Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol.
    Cardiovascular drugs and therapy, 1997, Volume: 11, Issue:2

    Topics: Acute Disease; Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction

1997
Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
    The American journal of cardiology, 1998, Jan-15, Volume: 81, Issue:2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Safety; Treatment Outcome

1998
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
    The American journal of cardiology, 1998, Jan-15, Volume: 81, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Coronary Angiography; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Safety; Treatment Outcome

1998
The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1998, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Aged; Amlodipine; Angiography; Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension, Renovascular; Middle Aged; Netherlands; Prognosis; Renal Artery Obstruction; Research Design; Retrospective Studies

1998
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    The American journal of cardiology, 1999, Feb-15, Volume: 83, Issue:4

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Treatment Outcome; Verapamil

1999
Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X.
    The American journal of cardiology, 1999, Oct-01, Volume: 84, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Analysis of Variance; Atenolol; Cross-Over Studies; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Microvascular Angina; Middle Aged; Statistics, Nonparametric; Treatment Outcome; Vasodilator Agents

1999
Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. Anglo-Scandinavian Cardiac Outcome Trial.
    Journal of human hypertension, 2000, Volume: 14, Issue:1

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Diuretics; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Survival Rate; Treatment Outcome

2000
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
    American journal of respiratory and critical care medicine, 2000, Volume: 161, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Single-Blind Method; Sleep Apnea, Obstructive; Sodium Chloride Symporter Inhibitors

2000
Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
    Archives of internal medicine, 2000, May-22, Volume: 160, Issue:10

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Quality of Life; Treatment Outcome; Verapamil

2000
Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
    Clinical cardiology, 2000, Volume: 23, Issue:10

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Nitrates

2000
Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension.
    International journal of clinical practice, 2000, Volume: 54, Issue:7

    Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Atenolol; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome

2000
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
    Journal of human hypertension, 2001, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cohort Studies; Drug Resistance; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renal; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiography; Renal Artery; Renal Artery Obstruction

2001
Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
    American journal of hypertension, 2002, Volume: 15, Issue:2 Pt 1

    Topics: Acetylcholine; Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Arteries; Atenolol; Buttocks; Calcium Channel Blockers; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Reference Values; Vascular Resistance; Vasodilation; Vasodilator Agents

2002
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cross-Sectional Studies; Electrocardiography; Female; Hematocrit; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; P-Selectin; Perindopril; Regression Analysis; Single-Blind Method; Treatment Outcome; von Willebrand Factor

2002
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
    Journal of the American College of Cardiology, 2002, Sep-04, Volume: 40, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide; Male; Middle Aged; Myocardial Ischemia

2002
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6

    Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed

2002
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes T
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:5

    Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Hemorheology; Humans; Hypercholesterolemia; Hyperemia; Hypertension; Male; Middle Aged; Models, Biological; Risk; Risk Management; Treatment Outcome; Ultrasonography; von Willebrand Factor

2003
Haemodynamic comparison of amlodipine and atenolol in essential hypertension using the quantascope.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Hypertension; Middle Aged; Stroke Volume; Ultrasonography, Doppler; Vascular Resistance

1993
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    JAMA, 2004, Jan-21, Volume: 291, Issue:3

    Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis

2004
Effect of different antihypertensive drug classes on central aortic pressure.
    American journal of hypertension, 2004, Volume: 17, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Aorta; Atenolol; Blood Pressure; Brachial Artery; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Enalapril; Female; Humans; Male; Treatment Outcome

2004
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
    Diabetes research and clinical practice, 2006, Volume: 72, Issue:3

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1

2006
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Circulation, 2006, Mar-07, Volume: 113, Issue:9

    Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Sodium Chloride Symporter Inhibitors; Treatment Outcome

2006
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Circulation, 2006, May-09, Volume: 113, Issue:18

    Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome

2006
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:2

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Capsules; Captopril; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged

2007
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    American journal of hypertension, 2007, Volume: 20, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Diuretics; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Perindopril; Platelet Activation; United Kingdom; Vascular Resistance; von Willebrand Factor

2007
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People

2007
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Heart (British Cardiac Society), 2008, Volume: 94, Issue:2

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease-Free Survival; Drug Costs; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Markov Chains; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Quality-Adjusted Life Years; Smoking; Stroke

2008
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
    Diabetes care, 2008, Volume: 31, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Diabetic Angiopathies; Drug Therapy, Combination; England; Female; Humans; Hypertension; Male; Middle Aged; Patient Selection; Perindopril; Sweden

2008
Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:3

    Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Propafenone; Prospective Studies; Secondary Prevention; Tetrazoles; Valine; Valsartan

2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
    Journal of hypertension, 2008, Volume: 26, Issue:11

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Peripheral Vascular Diseases; Scandinavian and Nordic Countries; Stroke; Thiazides; United Kingdom

2008
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
    International journal of cardiology, 2010, Apr-01, Volume: 140, Issue:1

    Topics: Adipokines; Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Cholesterol, HDL; Comorbidity; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Single-Blind Method; Tetrazoles; Triglycerides

2010
Coronary heart disease benefits from blood pressure and lipid-lowering.
    International journal of cardiology, 2009, Jun-26, Volume: 135, Issue:2

    Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Blood Pressure; Coronary Disease; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Risk Factors; Risk Reduction Behavior; Sodium Chloride Symporter Inhibitors

2009
Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Journal of hypertension, 2009, Volume: 27, Issue:4

    Topics: Aged; Amlodipine; Atenolol; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Thiazides

2009
Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:2

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Linear Models; Male; Microcirculation; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Retinal Diseases; Retinal Vessels; Risk Assessment; Scandinavian and Nordic Countries; Severity of Illness Index; Treatment Outcome; United Kingdom

2009
Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
    Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Atenolol; Calcium Channel Blockers; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Humans; Imidazoles; Male; Olmesartan Medoxomil; Tetrazoles; Therapeutic Equivalency

2009
Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carotid Arteries; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Pulsatile Flow; Systole; Treatment Outcome

2009
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
    Journal of the American College of Cardiology, 2009, Sep-22, Volume: 54, Issue:13

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Proportional Hazards Models; Treatment Outcome

2009
[An experience of the use of a fixed atenolol amlodipine combination in real clinical practice: results of multicenter Russian study].
    Kardiologiia, 2009, Volume: 49, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Amlodipine; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Young Adult

2009
Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
    The Lancet. Neurology, 2010, Volume: 9, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Risk; Stroke

2010
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Severity of Illness Index; Single-Blind Method; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan; Young Adult

2010
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
    Investigacion clinica, 2010, Volume: 51, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Female; Humans; Male; Middle Aged; Nociceptors; Pindolol; Propranolol; Young Adult

2010
Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
    Journal of hypertension, 2011, Volume: 29, Issue:3

    Topics: Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged

2011
Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension.
    Acta cardiologica, 2011, Volume: 66, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Biomarkers; Collagen; Collagen Type I; Humans; Hypertension; Natriuretic Peptide, Brain; Peptide Fragments; Peptides; Procollagen; Ventricular Remodeling

2011
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
    Journal of hypertension, 2011, Volume: 29, Issue:10

    Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Diuretics; Drug Resistance; Female; Humans; Hypertension; Ireland; Male; Middle Aged; Perindopril; Risk Factors; Scandinavian and Nordic Countries; United Kingdom

2011
[Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].
    Terapevticheskii arkhiv, 2013, Volume: 85, Issue:5

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amlodipine; Angina, Stable; Atenolol; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Exercise Tolerance; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged; Quality of Life; Time Factors; Treatment Outcome; Triglycerides

2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Time; Treatment Failure; Ventricular Function, Left; White People

2014
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
    Lancet (London, England), 2017, 03-11, Volume: 389, Issue:10073

    Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome

2017
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Lancet (London, England), 2018, 09-29, Volume: 392, Issue:10153

    Topics: Adult; Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Cause of Death; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Risk Factors; United Kingdom

2018
The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial.
    European stroke journal, 2023, Volume: 8, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cross-Over Studies; Humans; Losartan; Prospective Studies; Randomized Controlled Trials as Topic

2023

Other Studies

80 other study(ies) available for amlodipine and atenolol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship

2003
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
    Journal of chromatography. A, 1995, May-12, Volume: 700, Issue:1-2

    Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil

1995
Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.
    Circulation, 1997, Jan-07, Volume: 95, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angina, Unstable; Atenolol; Blood Platelets; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flow Cytometry; Humans; Male; Nitroglycerin; Platelet Activation

1997
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
    Cardiologia (Rome, Italy), 1999, Volume: 44, Issue:3

    Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left

1999
Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.
    Journal of toxicology. Clinical toxicology, 1999, Volume: 37, Issue:4

    Topics: Adolescent; Adult; Amlodipine; Atenolol; Calcium Channel Blockers; Chemotherapy, Adjuvant; Female; Glucose; Hemodynamics; Humans; Insulin; Male; Middle Aged; Suicide, Attempted; Verapamil

1999
Simultaneous determination of atenolol and amlodipine in tablets by high-performance thin-layer chromatography.
    Journal of pharmaceutical and biomedical analysis, 2000, Volume: 21, Issue:6

    Topics: Amlodipine; Atenolol; Calibration; Chromatography, Thin Layer; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets

2000
A study of pulmonary profile of hypertensive patients--comparison of atenolol vs amlodipine.
    Indian journal of physiology and pharmacology, 1998, Volume: 42, Issue:4

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Humans; Hypertension; Total Lung Capacity; Vital Capacity

1998
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
    Journal of human hypertension, 2001, Volume: 15 Suppl 1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Benzothiadiazines; Coronary Disease; Diuretics; Humans; Hypertension; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors

2001
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
    Journal of human hypertension, 2001, Volume: 15 Suppl 1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic

2001
Comparative effects of atenolol-based and amlodipine-based antihypertensive therapy on QT dispersion in hypertensive subjects.
    Journal of human hypertension, 2001, Volume: 15 Suppl 1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Electrocardiography; Humans; Hypertension; Hypertrophy, Left Ventricular

2001
Differential response to amlodipine and atenolol mono-therapy for hypertension by ethnic group.
    Journal of human hypertension, 2001, Volume: 15 Suppl 1

    Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Atenolol; Black or African American; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Ethnicity; Humans; Hypertension; Logistic Models; Male; Multicenter Studies as Topic; Renin; Surveys and Questionnaires; White People

2001
Differential effects of antihypertensive drug therapy on arterial compliance.
    American journal of hypertension, 2002, Volume: 15, Issue:12

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Vascular Resistance

2002
Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats.
    Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:1

    Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Drug Synergism; Female; Hypertension; Male; Rats; Rats, Inbred SHR

2004
Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:2

    Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Evaluation, Preclinical; Drug Synergism; Female; Hypertension; Male; Nitrendipine; Rats; Rats, Inbred SHR

2004
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
    Kardiologiia, 2004, Volume: 44, Issue:3

    Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents

2004
Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats.
    Acta pharmacologica Sinica, 2005, Volume: 26, Issue:11

    Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hypertension, Renovascular; Male; Rats; Rats, Sprague-Dawley

2005
[ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
    MMW Fortschritte der Medizin, 2005, Sep-29, Volume: 147, Issue:39

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Doxazosin; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Sodium Chloride Symporter Inhibitors; Treatment Outcome

2005
The prevention of myocardial ultrastructural changes by perindopril, atenolol and amlodipine in chronic alcohol administered rats.
    Pharmacological research, 2006, Volume: 53, Issue:2

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Calcium Channel Blockers; Central Nervous System Depressants; Ethanol; Male; Microscopy, Electron; Myocardium; Perindopril; Rats; Rats, Wistar

2006
[Antihypertensive therapy: campaign of the giants].
    MMW Fortschritte der Medizin, 2005, Dec-15, Volume: 147, Issue:51-52

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Survival Analysis

2005
Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
    Prescrire international, 2006, Volume: 15, Issue:83

    Topics: Amlodipine; Atenolol; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Sodium Chloride Symporter Inhibitors; Treatment Outcome

2006
Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
    American journal of hypertension, 2006, Volume: 19, Issue:10

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Heart Rate; Hydrochlorothiazide; Hypertension; Losartan; Male; Ramipril; Rats; Rats, Wistar; Sympathetic Nervous System

2006
Letter by Nieminen et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
    Circulation, 2006, Oct-10, Volume: 114, Issue:15

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Reproducibility of Results; Stroke Volume

2006
Letter by Dart et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
    Circulation, 2006, Oct-10, Volume: 114, Issue:15

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Endpoint Determination; Female; Heart Rate; Humans; Hypertension; Male; Predictive Value of Tests; Stroke Volume; Treatment Outcome

2006
Letter by Cameron et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
    Circulation, 2006, Oct-10, Volume: 114, Issue:15

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Proportional Hazards Models; Stroke Volume; Treatment Outcome

2006
Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
    Circulation, 2006, Oct-10, Volume: 114, Issue:15

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Indapamide; Perindopril; Proportional Hazards Models; Reproducibility of Results; Stroke Volume; Treatment Outcome

2006
Ivabradine: new drug. Best avoided in stable angina.
    Prescrire international, 2007, Volume: 16, Issue:88

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Benzazepines; Calcium Channel Blockers; Cost-Benefit Analysis; Drug Approval; Europe; Humans; Randomized Controlled Trials as Topic; Verapamil

2007
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:6

    Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler

2007
Simultaneous high-performance liquid chromatographic determination of atenolol and amlodipine in pharmaceutical-dosage form.
    Pakistan journal of pharmaceutical sciences, 2007, Volume: 20, Issue:4

    Topics: Amlodipine; Analysis of Variance; Antihypertensive Agents; Atenolol; Chromatography, High Pressure Liquid; Drug Combinations; Reproducibility of Results; Tablets

2007
[Treating essential hypertension. Are beta blockers still first choice?].
    MMW Fortschritte der Medizin, 2007, May-03, Volume: 149, Issue:18

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke

2007
ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    American journal of nephrology, 2007, Volume: 27, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Pilot Projects; Renal Dialysis; Severity of Illness Index; Treatment Outcome

2007
Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats.
    Acta pharmacologica Sinica, 2007, Volume: 28, Issue:11

    Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Female; Male; Rats; Rats, Inbred SHR; Stroke; Survival Rate

2007
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5

    Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles

2008
Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol.
    Medical science monitor : international medical journal of experimental and clinical research, 2008, Volume: 14, Issue:5

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atenolol; Calcium Channel Blockers; Endothelial Cells; Ethanol; Male; Microscopy, Electron; Perindopril; Rats; Rats, Wistar

2008
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
    Vascular health and risk management, 2008, Volume: 4, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan

2008
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
    Clinical lung cancer, 2008, Volume: 9, Issue:4

    Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed

2008
[Hypertension--does it matter how blood pressure is lowered?].
    Ugeskrift for laeger, 2008, Sep-01, Volume: 170, Issue:36

    Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Bendroflumethiazide; Cardiovascular Diseases; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Treatment Outcome

2008
Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Acta pharmaceutica (Zagreb, Croatia), 2008, Volume: 58, Issue:3

    Topics: Aluminum; Amlodipine; Atenolol; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Packaging; Drug Stability; Excipients; Humidity; Polyvinyl Chloride; Reproducibility of Results; Tablets; Technology, Pharmaceutical; Temperature

2008
The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats.
    Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:4

    Topics: Amlodipine; Animals; Atenolol; Blood Pressure; Drug Therapy, Combination; Hemodynamics; Hypertension; Male; Organ Specificity; Rats; Rats, Sprague-Dawley; Regression Analysis; Time Factors

2009
Diabetes and hypertension: which is the best approach?
    Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:3

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic

2009
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
    PharmacoEconomics, 2009, Volume: 27, Issue:3

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Models, Economic; Pyrroles; Scandinavian and Nordic Countries; Treatment Outcome

2009
Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:2

    Topics: Adult; Amlodipine; Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sinoatrial Node

2010
An unusual phenomenon with entropy during induction of general anaesthesia.
    Anaesthesia and intensive care, 2010, Volume: 38, Issue:1

    Topics: Adrenergic beta-Antagonists; Amlodipine; Anesthesia, General; Anesthetics, Intravenous; Antihypertensive Agents; Atenolol; Cholecystectomy; Electroencephalography; Entropy; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Monitoring, Intraoperative; Propofol

2010
Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
    Journal of the American College of Cardiology, 2010, Apr-27, Volume: 55, Issue:17

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Diastole; Echocardiography, Doppler; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ventricular Function, Left

2010
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
    American journal of hypertension, 2010, Volume: 23, Issue:9

    Topics: Age Factors; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Confounding Factors, Epidemiologic; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Racial Groups; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome

2010
What your blood pressure isn't revealing.
    The Johns Hopkins medical letter health after 50, 2010, Volume: 22, Issue:9

    Topics: Adrenergic beta-Antagonists; American Heart Association; Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Coronary Disease; Diagnosis, Differential; Diastole; Diet, Sodium-Restricted; Humans; Hypertension; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Systole; Time Factors; United States

2010
Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2011, Volume: 33, Issue:2

    Topics: Adult; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Captopril; Case-Control Studies; Female; Humans; Hydrochlorothiazide; Hypertension; In Vitro Techniques; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Losartan; Male; Middle Aged; Neutrophils

2011
An economic evaluation of antihypertensive therapies based on clinical trials.
    Clinics (Sao Paulo, Brazil), 2012, Volume: 67, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Costs; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic

2012
I take three different blood pressure medications-six pills total-every day. They are isosorbide mononitrate, amlodipine, and atenolol. They seem to do a good job bringing down my blood pressure, but before my 6 p.m. atenolol and then later before my 10 p
    Heart advisor, 2011, Volume: 14, Issue:10

    Topics: Amlodipine; Atenolol; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Drug Administration Schedule; Health Status; Humans; Hypertension; Isosorbide Dinitrate; Vasodilator Agents

2011
Simultaneous estimation of amlodipine and atenolol in human plasma: a sensitive LC-MS/MS method validation and its application to a clinical PK study.
    Bioanalysis, 2013, Volume: 5, Issue:7

    Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chromatography, Liquid; Humans; Male; Sensitivity and Specificity; Tandem Mass Spectrometry

2013
Simultaneous determination of binary mixture of amlodipine besylate and atenolol based on dual wavelengths.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Volume: 149

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Drug Combinations; Limit of Detection; Spectrophotometry; Tablets

2015
Interaction of PEGylated anti-hypertensive drugs, amlodipine, atenolol and lisinopril with lipid bilayer membrane: A molecular dynamics simulation study.
    Biochimica et biophysica acta, 2015, Volume: 1848, Issue:8

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Diffusion; Dimyristoylphosphatidylcholine; Energy Transfer; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Lisinopril; Molecular Dynamics Simulation; Molecular Structure; Polyethylene Glycols; Software; Static Electricity; Structure-Activity Relationship; Time Factors; Water

2015
Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2015, Volume: 11, Issue:4

    Topics: Amlodipine; Atenolol; Hemodynamics; Humans; Male; Methylene Blue; Middle Aged; Shock; Valsartan; Vasodilation

2015
Simultaneous enantioseparation and purity determination of chiral switches of amlodipine and atenolol by liquid chromatography.
    Journal of pharmaceutical and biomedical analysis, 2016, Feb-20, Volume: 120

    Topics: Amlodipine; Atenolol; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Contamination; Stereoisomerism

2016
Spectrophotometric Methods for Simultaneous Determination of Amlodipine Besylate and Atenolol in Their Tablet Dosage Form.
    Guang pu xue yu guang pu fen xi = Guang pu, 2015, Volume: 35, Issue:12

    Topics: Amlodipine; Atenolol; Calibration; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry; Tablets

2015
Combination of anti-hypertensive drugs: a molecular dynamics simulation study.
    Journal of molecular modeling, 2017, Volume: 23, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Dimyristoylphosphatidylcholine; Humans; Hydrogen Bonding; Hypertension; Lipid Bilayers; Lisinopril; Molecular Conformation; Molecular Dynamics Simulation; Software; Water

2017
Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: A cross-sectional study.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, Volume: 40, Issue:2

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization; Enalapril; Female; Guideline Adherence; Humans; Hypertension; Internal Medicine; Male; Middle Aged; Outpatient Clinics, Hospital; Polypharmacy; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tertiary Care Centers

2018
Alteration of serum immunoglobins, C-reactive protein, vitamin D, and electrolyte by atenolol and amlodipine in stress-induced hypertensive rats.
    Molecular and cellular biochemistry, 2018, Volume: 445, Issue:1-2

    Topics: Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; C-Reactive Protein; Calcium; Electrolytes; Female; Hypertension; Immunoglobulin G; Immunoglobulin M; Male; Potassium; Rats, Wistar; Sodium; Stress, Physiological; Vitamin D

2018
Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.
    Hypertension (Dallas, Tex. : 1979), 2019, Volume: 74, Issue:4

    Topics: Accidental Falls; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Male; Medicare; Syncope; Treatment Outcome; United States

2019
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Journal of hypertension, 2020, Volume: 38, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome

2020
Reduction of blood pressure variability: an additional protective cardiovascular effect of vasodilating beta-blockers?
    Journal of hypertension, 2020, Volume: 38, Issue:3

    Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Atenolol; Blood Pressure; Rats; Rats, Inbred SHR

2020
Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
    Journal of hypertension, 2020, Volume: 38, Issue:3

    Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Cytokines; Heart Ventricles; Rats; Rats, Inbred SHR

2020
Long-Term Incidence of Stroke and Dementia in ASCOT.
    Stroke, 2021, Volume: 52, Issue:10

    Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Cholesterol; Dementia; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Risk Factors; Scandinavian and Nordic Countries; Stroke; Treatment Outcome; United Kingdom

2021
Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2022, Volume: 38, Issue:2

    Topics: Amlodipine; Atenolol; Blood Flow Velocity; Blood Pressure; Humans; Hypertension; Intraocular Pressure; Ophthalmic Artery; Prospective Studies

2022
Zeolitic imidazolate framework-67-modified open-tubular column with cyclodextrin for enantioseparation in capillary electrochromatography.
    Electrophoresis, 2022, Volume: 43, Issue:13-14

    Topics: Amlodipine; Atenolol; Capillary Electrochromatography; Cyclodextrins; Histidine; Metoprolol; Propranolol; Stereoisomerism; Zeolites

2022
Carboxymethyl-β-cyclodextrin and histidine-zeolitic imidazolate framework-8 used for enantioseparation of three basic drugs in open-tubular capillary electrochromatography.
    Chirality, 2022, Volume: 34, Issue:9

    Topics: Amlodipine; Atenolol; beta-Cyclodextrins; Capillary Electrochromatography; Histidine; Propranolol; Stereoisomerism; Zeolites

2022
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
    Drug testing and analysis, 2022, Volume: 14, Issue:10

    Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry

2022
A super-hydrophilic partially reduced graphene oxide membrane with improved stability and antibacterial properties.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2022, Volume: 86, Issue:6

    Topics: Amlodipine; Anti-Bacterial Agents; Atenolol; Calcium Chloride; Carbamazepine; Chlorides; Graphite; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Membranes, Artificial; Pharmaceutical Preparations; Piperazines; Polyphenols; Salts; Sodium Chloride; Tea; Water

2022
Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats.
    Scientific reports, 2023, 03-01, Volume: 13, Issue:1

    Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Carotid Artery, Common; Hypertension; Hypotension; Rats; Rats, Inbred SHR; Rats, Inbred WKY

2023
Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2024, Jan-15, Volume: 305

    Topics: Amlodipine; Atenolol; Humans; Pharmaceutical Preparations; Spectrometry, Fluorescence

2024